
Alps Group Inc
ALPSHealthcare|Biotechnology|MY
$0.33
+0.02 (+4.90%)
DCF Value
$0.11
Cash / Share
$0.17
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Jan 21, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (3)
Aug 2027
Est. completion
NASpinocerebellar Ataxia
Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients
NCT06633003n=60
Oct 2027
Est. completion
Oct 2031
Est. completion
NAHealthy Subjects (HS)
Methodological Study of Exercise and Hypoxic Conditions in Healthy Subjects
NCT07671638n=305
Awaiting Results (3)
Trials past primary completion date but still active — data readout may be imminent.
Feb 2026
Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program
NCT06230016Dec 2024
Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF
NCT05128123Recent Press Releases
SEC Filings (39)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 15, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 7, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 6, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Jul 31, 2026 | NT 20-F | DocumentIndex | |
| Jun 23, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 19, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 17, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 23, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 5, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 21, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jan 20, 2026 | EFFECT | DocumentIndex | |
| Jan 8, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 7, 2026 | F-1 | IPO / offering registration | DocumentIndex |
| Nov 12, 2025 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Nov 3, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 3, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Oct 31, 2025 | 20-F | Annual report (foreign) | DocumentIndex |
| Oct 31, 2025 | 6-K/A | Foreign issuer report | DocumentIndex |
| Oct 30, 2025 | CERT | DocumentIndex | |
| Oct 30, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 27, 2025 | 8-A12B | DocumentIndex | |
| Oct 10, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 1, 2025 | 425 | DocumentIndex | |
| Sep 23, 2025 | SEC STAFF LETTER | DocumentIndex | |
| Sep 17, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 12, 2025 | EFFECT | DocumentIndex | |
| Sep 8, 2025 | F-4/A | DocumentIndex | |
| Aug 29, 2025 | F-4/A | DocumentIndex | |
| Jul 25, 2025 | F-4/A | DocumentIndex | |
| Jun 27, 2025 | F-4/A | DocumentIndex | |
| Jun 9, 2025 | F-4/A | DocumentIndex | |
| Apr 25, 2025 | F-4/A | DocumentIndex | |
| Apr 18, 2025 | F-4/A | DocumentIndex | |
| Apr 1, 2025 | F-4/A | DocumentIndex | |
| Dec 23, 2024 | F-4 | DocumentIndex |